Matches in Wikidata for { <http://www.wikidata.org/entity/Q38558640> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- Q38558640 description "2016 nî lūn-bûn" @default.
- Q38558640 description "2016年の論文" @default.
- Q38558640 description "2016年論文" @default.
- Q38558640 description "2016年論文" @default.
- Q38558640 description "2016年論文" @default.
- Q38558640 description "2016年論文" @default.
- Q38558640 description "2016年論文" @default.
- Q38558640 description "2016年论文" @default.
- Q38558640 description "2016年论文" @default.
- Q38558640 description "2016年论文" @default.
- Q38558640 description "2016年论文" @default.
- Q38558640 description "2016年论文" @default.
- Q38558640 description "2016年论文" @default.
- Q38558640 description "2016년 논문" @default.
- Q38558640 description "article científic" @default.
- Q38558640 description "article scientific" @default.
- Q38558640 description "article scientifique" @default.
- Q38558640 description "articol științific" @default.
- Q38558640 description "articolo scientifico" @default.
- Q38558640 description "artigo científico" @default.
- Q38558640 description "artigo científico" @default.
- Q38558640 description "artigo científico" @default.
- Q38558640 description "artikel ilmiah" @default.
- Q38558640 description "artikull shkencor" @default.
- Q38558640 description "artikulong pang-agham" @default.
- Q38558640 description "artykuł naukowy" @default.
- Q38558640 description "artículo científico" @default.
- Q38558640 description "artículu científicu espublizáu en 2016" @default.
- Q38558640 description "bilimsel makale" @default.
- Q38558640 description "bài báo khoa học" @default.
- Q38558640 description "naučni članak" @default.
- Q38558640 description "scienca artikolo" @default.
- Q38558640 description "scientific article published on 16 December 2016" @default.
- Q38558640 description "scientific article published on 16 December 2016" @default.
- Q38558640 description "scientific article published on 16 December 2016" @default.
- Q38558640 description "teaduslik artikkel" @default.
- Q38558640 description "tieteellinen artikkeli" @default.
- Q38558640 description "tudományos cikk" @default.
- Q38558640 description "vedecký článok" @default.
- Q38558640 description "vetenskaplig artikel" @default.
- Q38558640 description "videnskabelig artikel" @default.
- Q38558640 description "vitenskapelig artikkel" @default.
- Q38558640 description "vitskapeleg artikkel" @default.
- Q38558640 description "vědecký článek" @default.
- Q38558640 description "wetenschappelijk artikel" @default.
- Q38558640 description "wissenschaftlicher Artikel" @default.
- Q38558640 description "επιστημονικό άρθρο" @default.
- Q38558640 description "мақолаи илмӣ" @default.
- Q38558640 description "наукова стаття, опублікована в грудні 2016" @default.
- Q38558640 description "научна статия" @default.
- Q38558640 description "научная статья" @default.
- Q38558640 description "научни чланак" @default.
- Q38558640 description "научни чланак" @default.
- Q38558640 description "מאמר מדעי" @default.
- Q38558640 description "مقالة علمية نشرت في 16 ديسمبر 2016" @default.
- Q38558640 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38558640 description "บทความทางวิทยาศาสตร์" @default.
- Q38558640 description "სამეცნიერო სტატია" @default.
- Q38558640 name "Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels" @default.
- Q38558640 name "Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels" @default.
- Q38558640 name "Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels" @default.
- Q38558640 type Item @default.
- Q38558640 label "Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels" @default.
- Q38558640 label "Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels" @default.
- Q38558640 label "Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels" @default.
- Q38558640 prefLabel "Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels" @default.
- Q38558640 prefLabel "Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels" @default.
- Q38558640 prefLabel "Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels" @default.
- Q38558640 P1433 Q38558640-EFF2DD14-5972-444B-8B2C-35F3B2F753EF @default.
- Q38558640 P1476 Q38558640-9003A595-C191-43FD-941F-E93E504DF667 @default.
- Q38558640 P2093 Q38558640-043CA315-49B5-412A-9C32-B65B1DABD71F @default.
- Q38558640 P2093 Q38558640-257DBD56-3F48-4ECA-A73D-92381012ADFD @default.
- Q38558640 P2093 Q38558640-3105D155-B3D0-41E8-870C-AB62E41D81EA @default.
- Q38558640 P304 Q38558640-4ACA7884-19AB-4496-BD6C-334282961DCD @default.
- Q38558640 P31 Q38558640-4F24F2EC-35DB-4386-9912-914870F65C3E @default.
- Q38558640 P356 Q38558640-655AA4A9-189F-41AA-80BA-E75A276FA275 @default.
- Q38558640 P407 Q38558640-C72EF1EA-AEB3-4081-8CC6-0767A62C1560 @default.
- Q38558640 P433 Q38558640-376FC8A5-010A-4CAD-871B-7675B7BF2933 @default.
- Q38558640 P478 Q38558640-57EF049F-73D2-40D0-ACB8-60F26D42668D @default.
- Q38558640 P50 Q38558640-99725705-CAB9-4CA8-8620-20DE226862E6 @default.
- Q38558640 P577 Q38558640-112350D9-E049-4BEA-8D77-5D1B53150645 @default.
- Q38558640 P698 Q38558640-56955702-2B8C-478D-8318-AE2DF963377E @default.
- Q38558640 P921 Q38558640-9A9FDF55-1650-40E8-B14E-75299F09904E @default.
- Q38558640 P356 ACS.MOLPHARMACEUT.6B00967 @default.
- Q38558640 P698 27981848 @default.
- Q38558640 P1433 Q3011140 @default.
- Q38558640 P1476 "Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels" @default.
- Q38558640 P2093 "Avital Beig" @default.
- Q38558640 P2093 "David Lindley" @default.
- Q38558640 P2093 "Jonathan M Miller" @default.
- Q38558640 P304 "319-327" @default.
- Q38558640 P31 Q13442814 @default.
- Q38558640 P356 "10.1021/ACS.MOLPHARMACEUT.6B00967" @default.
- Q38558640 P407 Q1860 @default.
- Q38558640 P433 "1" @default.
- Q38558640 P478 "14" @default.
- Q38558640 P50 Q88065979 @default.
- Q38558640 P577 "2016-12-16T00:00:00Z" @default.
- Q38558640 P698 "27981848" @default.
- Q38558640 P921 Q410412 @default.